Boehringer Ingelheim Backs R&D With Big Bucks
Reports Solid Set Of Financials For 2020
Jardiance and Ofev are growing strongly but the German drugmaker is also confident its pipeline will bear fruit, boosted by a rising research budget that represents almost 23% of sales.
